TY - JOUR
T1 - Designer cellular spheroids with DNA origami for drug screening
AU - Wei, Jiayi
AU - Sun, Yueyang
AU - Wang, Heming
AU - Zhu, Tong
AU - Li, Li
AU - Zhou, Ying
AU - Liu, Quan
AU - Dai, Zhen
AU - Li, Wenjuan
AU - Yang, Taihua
AU - Wang, Bingmei
AU - Zhu, Changfeng
AU - Shen, Xizhong
AU - Yao, Qunyan
AU - Song, Guangqi
AU - Zhao, Yicheng
AU - Pei, Hao
N1 - Publisher Copyright:
© 2024 The Authors.
PY - 2024/7
Y1 - 2024/7
N2 - Current in vitro models struggle to balance the complexity of human diseases with suitability for large-scale drug tests. While 3D cultures simulate human tissues, they lack cellular intricacy, and integrating these models with high-throughput drug screening remains a challenge. Here, we introduce a method that uses self-assembling nucleic acid nanostructures decorated living cells, termed NACs, to create spheroids with a customizable 3D layout. To demonstrate its uniqueness, our method effectively creates designer 3D spheroids by combining parenchymal cells, stromal cells, and immune cells, leading to heightened physiological relevance and detailed modeling of complex chronic diseases and immune-stromal interactions. Our approach achieves a high level of biological fidelity while being standardized and straightforward to construct with the potential for large-scale drug discovery applications. By merging the precision of DNA nanotechnology with advanced cell culture techniques, we are streamlining human-centric models, striking a balance between complexity and standardization, to boost drug screening efficiency.
AB - Current in vitro models struggle to balance the complexity of human diseases with suitability for large-scale drug tests. While 3D cultures simulate human tissues, they lack cellular intricacy, and integrating these models with high-throughput drug screening remains a challenge. Here, we introduce a method that uses self-assembling nucleic acid nanostructures decorated living cells, termed NACs, to create spheroids with a customizable 3D layout. To demonstrate its uniqueness, our method effectively creates designer 3D spheroids by combining parenchymal cells, stromal cells, and immune cells, leading to heightened physiological relevance and detailed modeling of complex chronic diseases and immune-stromal interactions. Our approach achieves a high level of biological fidelity while being standardized and straightforward to construct with the potential for large-scale drug discovery applications. By merging the precision of DNA nanotechnology with advanced cell culture techniques, we are streamlining human-centric models, striking a balance between complexity and standardization, to boost drug screening efficiency.
UR - https://www.scopus.com/pages/publications/85199236062
U2 - 10.1126/sciadv.ado9880
DO - 10.1126/sciadv.ado9880
M3 - 文章
C2 - 39028810
AN - SCOPUS:85199236062
SN - 2375-2548
VL - 10
JO - Science Advances
JF - Science Advances
IS - 29
M1 - ado9880
ER -